The addition of accurate assessment of the local extent of prostate cancer reported herein provides additional rationale for PSMA-PET to be used as a “one-stop-shop” imaging modality in the primary staging of prostate cancer. The gene discussed is FOLH1; the disease is prostate carcinoma.